Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
-
401
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025Subjects: -
402
-
403
-
404
-
405
-
406
-
407
-
408
-
409
-
410
Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.
Published 2025Subjects: -
411
Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.
Published 2025Subjects: -
412
Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.
Published 2025Subjects: -
413
NTM infection induces mitochondrial damage and reduces mitochondria number.
Published 2025Subjects: -
414
Loxoprofen and SB225002 administration decreased sound stress exposure-induced hyperalgesia.
Published 2025“…Mice treated with loxoprofen (500 mg/kg) or SB225002 (3 mg/kg) showed significantly decreased response times to the filament compared to Stress + saline group (Stress + loxoprofen (500 mg/kg), 30 min after administration, **<i>P</i> < 0.01, 60 min after administration, ***<i>P</i><i> <i><</i> </i>0.001; Stress + SB225002 (3 mg/kg), 60 min after administration, *<i>P</i> < 0.05). 2-way ANOVA <i>post-hoc</i> Bonferroni test. …”
-
415
-
416
-
417
Activity of female and male <i>M. marinus</i> (left column) and <i>G. pulex</i> (right column).
Published 2025Subjects: -
418
-
419
-
420